Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA)

Authors: Lee, Jii Bum ^a, Choi, Su-Jin ^a, Shim, Hyo Sup ^b, Park, Byung Jo ^c, Lee, Chang Young ^c, Sudhaman, Sumedha ^d, Velichko, Sharlene ^d, Hong, Min Hee ^a, Cho, Byoung Chul ^a, Lim, Sun Min ^{a, ∗}

Source: In Journal of Thoracic Oncology May 2025 20(5):641-650

Association of thyroid radiation dose with thyroid dysfunction in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy followed by maintenance immunotherapy

Authors: Yang, Gowoon ^{a, b}, Yoon, Hong In ^b, Lim, Sun Min ^c, Hong, Min Hee ^c, Cho, Jaeho ^b, Lee, Chang Geol ^b, Cho, Byoung Chul ^c, Kim, Hye Ryun ^c, Kim, Kyung Hwan ^{b, ⁎}

Source: In Lung Cancer June 2025 204

The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC

Authors: Oh, Seung Yeon ^{1, 8}, Park, Sewon ^{2, 8}, Lee, Seoyoung ³, Lee, Eun Ji ¹, Kim, Tae Ho ⁴, Choi, Su-Jin ⁴, Park, So Young ⁴, Kim, Jae Hwan ⁵, Lim, Sun Min ⁶, Lee, Jii Bum ⁶, Cho, Byoung Chul ⁶, Hong, Min Hee ^{6, ∗}, Yun, Mi Ran ^{5, 7, 9, ∗∗}

Source: In Cell Reports Medicine 18 February 2025 6(2)

Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study

Authors: Kim, Yong Joon, Lee, Myeongjee, Kim, Eun Hwa, Lee, Seulkee, Park, Sejung, Hong, Min Hee, Shin, Sang Joon, Jung, Inkyung, Lee, Choong-kun, Lee, Christopher Seungkyu

Source: In Cancer Letters 1 August 2024 596

Usefulness of bronchial washing fluid for detection of EGFR mutations in non-small cell lung cancer

Authors: Ryu, Woo Kyung, Yong, Seung Hyun, Lee, Sang Hoon, Gwon, Hye Ran, Kim, Hye Ryun, Hong, Min Hee, Oh, Go Eun, Jung, Sehee, Kim, Chi Young, Chang, Yoon Soo, Kim, Eun Young

Source: In Lung Cancer December 2023 186

Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study

Authors: Kim, Hyunwook, Ahn, Beung-Chul, Lee, Jiyun, Lee, Jii Bum, Hong, Min-Hee, Kim, Hye Ryun, Cho, Byoung Chul, Lim, Sun Min

Source: In Lung Cancer June 2023 180

Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea

Authors: Ahn, Beung-Chul, Lee, Seoyoung, Lee, Jiyun, Lee, Jii Bum, Hong, Min Hee, Lim, Sun Min, Jain, Suyog, Olsen, Steve, Cho, Byoung Chul

Source: In Cancer Treatment and Research Communications 2023 36

Single‐cell multi‐omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK‐positive lung cancer.

Authors: Baek, Seungbyn, Sung, Euijeong, Kim, Gamin, Hong, Min Hee, Lee, Chang Young, Shim, Hyo Sup, Park, Seong Yong, Kim, Hye Ryun, Lee, Insuk

Source: Cancer Communications; Apr2025, Vol. 45 Issue 4, p422-427, 6p

A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors

Authors: Cho, Byoung Chul, Han, Ji-Youn, Kim, Sang-We, Lee, Ki Hyeong, Cho, Eun Kyung, Lee, Yun-Gyoo, Kim, Dong-Wan, Kim, Joo-Hang, Lee, Gyeong-Won, Lee, Jong-Seok, Shim, Byoung Yong, Kim, Jin-Soo, Chun, Sang Hoon, Lee, Sung Sook, Kim, Hye Ryun, Hong, Min Hee, Ahn, Jin Seok, Sun, Jong-Mu, Lee, Youngjoo, Lee, Dae Ho, Kang, Ji Ah, Lee, NaMi, Kwon, Mi-Jung, Espenschied, Carin, Yablonovitch, Arielle, Ahn, Myung-Ju

Source: In Journal of Thoracic Oncology April 2022 17(4):558-567

Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy

Authors: Cho, Yeona, Kim, Yejin, Chamseddine, Ibrahim, Lee, Won Hee, Kim, Hye Ryun, Lee, Ik Jae, Hong, Min Hee, Cho, Byung Chul, Lee, Chang Geol, Cho, Seungryong, Kim, Jin Sung, Yoon, Hong In, Grassberger, Clemens

Source: In Radiotherapy and Oncology March 2022 168:1-7

Clinical decision support algorithm based on machine learning to assess the clinical response to anti–programmed death-1 therapy in patients with non–small-cell lung cancer

Authors: Ahn, Beung-Chul, So, Jea-Woo, Synn, Chun-Bong, Kim, Tae Hyung, Kim, Jae Hwan, Byeon, Yeongseon, Kim, Young Seob, Heo, Seong Gu, Yang, San-Duk, Yun, Mi Ran, Lim, Sangbin, Choi, Su-Jin, Lee, Wongeun, Kim, Dong Kwon, Lee, Eun Ji, Lee, Seul, Lee, Doo-Jae, Kim, Chang Gon, Lim, Sun Min, Hong, Min Hee, Cho, Byoung Chul, Pyo, Kyoung-Ho, Kim, Hye Ryun

Source: In European Journal of Cancer August 2021 153:179-189

Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer

Authors: Kim, Chang Gon, Hong, Min Hee, Kim, Kyung Hwan, Seo, In-Ho, Ahn, Beung-Chul, Pyo, Kyoung-Ho, Synn, Chun-Bong, Yoon, Hong In, Shim, Hyo Sup, Lee, Yong Il, Choi, Seong Jin, Lee, Yun Jeong, Kim, Ellen Janine, Kim, Youngun, Kwak, Jeong-Eun, Jung, Jaehyung, Park, Su-Hyung, Paik, Soonmyung, Shin, Eui-Cheol, Kim, Hye Ryun

Source: In European Journal of Cancer January 2021 143:113-126

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.

Authors: Ahn, Myung-Ju¹ (AUTHOR), Tanaka, Kentaro² (AUTHOR), Paz-Ares, Luis³ (AUTHOR), Cornelissen, Robin⁴ (AUTHOR), Girard, Nicolas⁵ (AUTHOR), Pons-Tostivint, Elvire⁶ (AUTHOR), Vicente Baz, David⁷ (AUTHOR), Sugawara, Shunichi⁸ (AUTHOR), Cobo, Manuel⁹ (AUTHOR), Pérol, Maurice¹⁰ (AUTHOR), Mascaux, Céline¹¹ (AUTHOR), Poddubskaya, Elena¹² (AUTHOR), Kitazono, Satoru¹³ (AUTHOR), Hayashi, Hidetoshi¹⁴ (AUTHOR), Hong, Min Hee¹⁵ (AUTHOR), Felip, Enriqueta¹⁶ (AUTHOR), Hall, Richard¹⁷ (AUTHOR), Juan-Vidal, Oscar¹⁸ (AUTHOR), Brungs, Daniel¹⁹ (AUTHOR), Lu, Shun²⁰ (AUTHOR)

Source: Journal of Clinical Oncology. 1/20/2025, Vol. 43 Issue 3, p260-272. 20p.

A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapy.

Authors: Kim, Chan Yeong, Park, Dong Jin, Ahn, Beung Chul, Baek, Seungbyn, Hong, Min Hee, Nguyen, Linh Thanh, Hwang, Sun Ha, Kim, Nayeon, Podlesny, Daniel, Orakov, Askarbek, Schudoma, Christian, Robbani, Shahriyar Mahdi, Shim, Hyo Sup, Yoon, Hong In, Lee, Chang Young, Park, Seong Yong, Yong, Dongeun, Han, Mina, Bork, Peer, Kim, Byoung Choul

Source: Nature Communications; 12/27/2024, Vol. 15 Issue 1, p1-19, 19p

Subject Terms: TREATMENT effectiveness, IMMUNE checkpoint proteins, GUT microbiome, MEDICAL sciences, BIOMARKERS, MICE

Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma.

Authors: Sim, Yongsik, Sohn, Beomseok, Kim, Sooyon, Kim, Hye Ryun, Hong, Min Hee, Kim, Jinna, Lee, Seung-Koo, Lim, Sun Min

Source: Future Oncology; 2024, Vol. 20 Issue 36, p2869-2878, 10p

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12).

Authors: Lee, Dong Ki, Park, Sook Ryun, Kim, Yeul Hong, Lee, Yun-Gyoo, Shin, Su-Jin, Ahn, Beung-Chul, Lee, Sung Sook, Lim, Sun Min, Kim, Hye Ryun, Cho, Byoung Chul, Hong, Min Hee

Source: OncoImmunology; 2024, Vol. 13 Issue 1, p1-12, 12p

Subject Terms: PROGRAMMED death-ligand 1, IMMUNE checkpoint inhibitors, SQUAMOUS cell carcinoma, OVERALL survival, PROGRESSION-free survival

Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

Authors: Ahn, Myung-Ju ^a, Han, Ji-Youn ^c, Lee, Ki Hyeong ^d, Kim, Sang-We ^e, Kim, Dong-Wan ^f, Lee, Yun-Gyoo ^b, Cho, Eun Kyung ^g, Kim, Joo-Hang ^h, Lee, Gyeong-Won ⁱ, Lee, Jong-Seok ^j, Min, Young Joo ^k, Kim, Jin-Soo ^l, Lee, Sung Sook ^m, Kim, Hye Ryun ⁿ, Hong, Min Hee ⁿ, Ahn, Jin Seok ^a, Sun, Jong-Mu ^a, Kim, Heung Tae ^c, Lee, Dae Ho ^e, Kim, Sohee ^o, Cho, Byoung Chul ^{n, *}

Source: In The Lancet Oncology December 2019 20(12):1681-1690

Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy

Authors: Choe, Eun-Ah, Cha, Yoon Jin, Kim, Jae-Hwan, Pyo, Kyoung Ho, Hong, Min Hee, Park, Seong Yong, Shim, Hyo Sup, Jung, Inkyung, Lee, Chang Young, Cho, Byoung Chul, Kim, Hye Ryun

Source: In Lung Cancer October 2019 136:30-36

Ti doping effects on the Seebeck coefficient and electrical conductivity of mesoporous ZnO thin film

Authors: Hong, Min-Hee, Choi, Haryeong, Kim, Younghun, Kim, Taehee, Cho, Hyung Hee, Driss, Zied, Driss, Dorra, Bouabidi, Abdallah, Euchy, Souhir, Park, Hyung-Ho

Source: In Materials Chemistry and Physics 1 September 2019 235

A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs

Authors: Park, Ji Soo, Hong, Min Hee, Chun, You Jin, Kim, Hye Ryun, Cho, Byoung Chul

Source: In Lung Cancer August 2019 134:46-51